Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 50 EP074 | DOI: 10.1530/endoabs.50.EP074

SFEBES2017 ePoster Presentations Neuroendocrinology and Pituitary (23 abstracts)

Recurrent lymphocytic hypophysitis during two pregnancies: a very rare case

Joht Singh Chandan 1, , Neil Gittoes 1, , Andrew Toogood 2, & Niki Karavitaki 1,


1Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; 2Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK; 3Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.


Lymphocytic hypophysitis (LyH) is a rare condition often associated with pregnancy (usually presenting in the last month of pregnancy or in the first two post-partum months). We describe a very rare case of recurrent LyH during two pregnancies.

A 25-years old woman presented in 7/2003 with a 6-week history of headaches and a 2-week history of visual deterioration whilst 38 weeks pregnant. Bitemporal hemianopia was confirmed and pituitary MRI revealed a sellar mass deforming the chiasm. Secondary hypothyroidism was found and levothyroxine was started. Hydrocortisone was also added. She had induction of labour two days later and she delivered a healthy boy. Two days after delivery, she had urgent transsphenoidal removal of the mass; pathology was consistent with LyH. Post-operatively, she made good recovery with marked visual improvement. Short Synacthen test was normal and she was breastfeeding. Pituitary MRI (11/2003) revealed a small amount of tissue within an enlarged fossa with no significant suprasellar extension. In 1/2004, she conceived again and at the 14th week of pregnancy she was experiencing increasingly generalised headaches and bilateral visual disturbance. MRI (3/2004) showed pituitary enlargement elevating the chiasm. She had bitemporal field defects and she was put on hydrocortisone (final dose: 30 mg am, 15 mg pm). In the subsequent weeks, she had close visual monitoring and no further deterioration was detected. In 9/2004, she delivered a healthy boy. Post-partum, her vision returned to normal and follow-up imaging showed gradual resolution of the LyH. Her periods returned and adequate ACTH reserve was confirmed. She had no further pregnancies. In her latest follow-up (12/2016), she is on levothyroxine and GH replacement.

Although, it has been suggested that a history of LyH in pregnancy does not increase the risk of developing LyH in subsequent ones, our case demonstrates the variable natural history of this condition.

Volume 50

Society for Endocrinology BES 2017

Harrogate, UK
06 Nov 2017 - 08 Nov 2017

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.